2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.27+$0.009 (+3.40%)
Price as of Jun 23, 2026 7:51 PM EDT- $26.7MMarket Cap
- -14.07%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.27+$0.009 (+3.40%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.27 | ||
Change | -$0.008 (-3.02%) | ||
Open | $0.27 | ||
High | $0.29 | ||
Low | $0.27 | ||
Previous Close | $0.27 | ||
Volume | 706,858 | ||
30-Day Average Volume | 622,000 | ||
1-Week Change | -4.92% | ||
1-Month Change | -7.43% | ||
1-Year Change | -12.70% | ||
3-Year Change | -11.13% | ||
5-Year Change | -81.99% | ||
Fundamentals | |||
Shares Outstanding | 100.1M | ||
Total Assets | $9.2M | ||
Market Cap | $26.7M | ||
Enterprise Value | $27.4M | ||
Period: QTR TTM FY | |||
Revenue | $317,000.00 | ||
Net Income | -$2.4M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$2.4M | ||
EBITDA | -$2.3M | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 86 | ||
P/B | 4 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue